HBsAg-Serum Protein Complexes Stimulate Immune T Lymphocytes More Efficiently Than Do Pure HBsAg
Open Access
- 1 November 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 4 (6) , 1116-1123
- https://doi.org/10.1002/hep.1840040604
Abstract
HBsAg from plasma of chronic hepatitis B carriers was purified by affinity chomatography using a mouse monoclonal antibody specific for HBsAg. Elution with buffer at two different pH values separated HBsAg into two fractions: one contained high amounts of immune complexes associated with HBsAg; the other contained larger quantities of the HBsAg polypeptides P24 and GP27 and only small amounts of immunoglobulin. When compared for effects on stimulating the proliferative response of freshly isolated lymphocytes and an HBsAg-specific T cell clone, the HBsAg fraction containing a high proportion of immunoglobulin was much more potent than HBsAg with low amounts of immunoglobulins or pure HBsAg, which was isolated from the culture supernatant of the human hepatoma cell line (PLC/PRF/5). The plasma-derived HBsAg with low amounts of complexed immunoglobulins became more immunogenic in the presence of an anti-HBsAg monoclonal IgG. The present results, combined with earlier findings, suggest that HBsAg associated with immune complexes is a more potent stimulator of T cells than purer HBsAg preparations due to an increase in the efficiency of monocytes to capture the antigen through binding to immune complexes for subsequent processing and presentation of the antigen. These observations could be of relevance for the preparation of effective hepatitis B vaccines from recombinant DNA and peptide synthesis technologies.This publication has 49 references indexed in Scilit:
- Passive-active immunisation of neonates of HBsAg positive carrier mothers: preliminary observations.BMJ, 1984
- Hepatitis B and Immune-Complex DiseaseNew England Journal of Medicine, 1984
- Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.Journal of Clinical Investigation, 1983
- PERSISTENCE OF CIRCULATING HBsAg/IgM COMPLEXES IN ACUTE VIRAL HEPATITIS, TYPE B: AN EARLY MARKER OF CHRONIC EVOLUTIONThe Lancet, 1982
- Hepatitis B VaccineNew England Journal of Medicine, 1980
- Type B Hepatitis: A Review of Current Prospects for a Safe and Effective VaccineClinical Infectious Diseases, 1980
- Viral Hepatitis, Type BNew England Journal of Medicine, 1979
- Inactivated Venezuelan Equine Encephalomyelitis Virus Vaccine Complexed with Specific Antibody: Enhanced Primary Immune Response and Altered Pattern of Antibody Class ElicitedThe Journal of Infectious Diseases, 1977
- Approaching the Control of Viral Hepatitis Type BThe Journal of Infectious Diseases, 1976
- T-cell dependence of immune response to hepatitis B antigen in miceNature, 1975